Clinical Trial Update: A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports the completion of a study evaluating the safety and pharmacology of RGLS8429 in adults with autosomal dominant polycystic kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• RGLS8429

Snippet

Sponsor: Regulus Therapeutics Inc. | Conditions: Autosomal Dominant Polycystic Kidney Disease, ADPKD | Phase 1 | Status: COMPLETED